These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 24316020)
1. Surface plasmon resonance measurements of plasma antibody avidity during primary and secondary responses to anthrax protective antigen. Lynch HE; Stewart SM; Kepler TB; Sempowski GD; Alam SM J Immunol Methods; 2014 Feb; 404():1-12. PubMed ID: 24316020 [TBL] [Abstract][Full Text] [Related]
2. A combination of the TLR4 agonist CIA05 and alum promotes the immune responses to Bacillus anthracis protective antigen in mice. Wui SR; Kim HK; Han JE; Kim JM; Kim YH; Chun JH; Cho YJ; Lee NG Int Immunopharmacol; 2011 Sep; 11(9):1195-204. PubMed ID: 21492746 [TBL] [Abstract][Full Text] [Related]
3. BA3338, a surface layer homology domain possessing protein augments immune response and protection efficacy of protective antigen against Bacillus anthracis in mouse model. Kumar M; Puranik N; Varshney A; Tripathi N; Pal V; Goel AK J Appl Microbiol; 2020 Aug; 129(2):443-452. PubMed ID: 32118336 [TBL] [Abstract][Full Text] [Related]
4. Enhancement of antibody responses to Bacillus anthracis protective antigen domain IV by use of calreticulin as a chimeric molecular adjuvant. Park YS; Lee JH; Hung CF; Wu TC; Kim TW Infect Immun; 2008 May; 76(5):1952-9. PubMed ID: 18285494 [TBL] [Abstract][Full Text] [Related]
5. A CpG-Ficoll Nanoparticle Adjuvant for Anthrax Protective Antigen Enhances Immunogenicity and Provides Single-Immunization Protection against Inhaled Anthrax in Monkeys. Kachura MA; Hickle C; Kell SA; Sathe A; Calacsan C; Kiwan R; Hall B; Milley R; Ott G; Coffman RL; Kanzler H; Campbell JD J Immunol; 2016 Jan; 196(1):284-97. PubMed ID: 26608924 [TBL] [Abstract][Full Text] [Related]
6. Increased long-term immunity to Bacillus anthracis protective antigen in mice immunized with a CIA06B-adjuvanted anthrax vaccine. Wui SR; Han JE; Kim YH; Rhie GE; Lee NG Arch Pharm Res; 2013 Apr; 36(4):464-71. PubMed ID: 23440578 [TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of the immunologic response induced by the Sterne 34F2 live spore Bacillus anthracis vaccine in a ruminant model. Ndumnego OC; Köhler SM; Crafford J; van Heerden H; Beyer W Vet Immunol Immunopathol; 2016 Oct; 178():14-21. PubMed ID: 27496738 [TBL] [Abstract][Full Text] [Related]
11. Progress towards the Development of a NEAT Vaccine for Anthrax II: Immunogen Specificity and Alum Effectiveness in an Inhalational Model. Jelinski J; Terwilliger A; Green S; Maresso A Infect Immun; 2020 Jul; 88(8):. PubMed ID: 32393506 [No Abstract] [Full Text] [Related]
12. Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen. Boyaka PN; Tafaro A; Fischer R; Leppla SH; Fujihashi K; McGhee JR J Immunol; 2003 Jun; 170(11):5636-43. PubMed ID: 12759444 [TBL] [Abstract][Full Text] [Related]
13. A plant based protective antigen [PA(dIV)] vaccine expressed in chloroplasts demonstrates protective immunity in mice against anthrax. Gorantala J; Grover S; Goel D; Rahi A; Jayadev Magani SK; Chandra S; Bhatnagar R Vaccine; 2011 Jun; 29(27):4521-33. PubMed ID: 21504775 [TBL] [Abstract][Full Text] [Related]
14. CD1d-dependent B-cell help by NK-like T cells leads to enhanced and sustained production of Bacillus anthracis lethal toxin-neutralizing antibodies. Devera TS; Aye LM; Lang GA; Joshi SK; Ballard JD; Lang ML Infect Immun; 2010 Apr; 78(4):1610-7. PubMed ID: 20123711 [TBL] [Abstract][Full Text] [Related]
15. Nasal immunization with anthrax protective antigen protein adjuvanted with polyriboinosinic-polyribocytidylic acid induced strong mucosal and systemic immunities. Sloat BR; Cui Z Pharm Res; 2006 Jun; 23(6):1217-26. PubMed ID: 16718616 [TBL] [Abstract][Full Text] [Related]
16. Phase 1 study of a recombinant mutant protective antigen of Bacillus anthracis. Bellanti JA; Lin FY; Chu C; Shiloach J; Leppla SH; Benavides GA; Karpas A; Moayeri M; Guo C; Robbins JB; Schneerson R Clin Vaccine Immunol; 2012 Feb; 19(2):140-5. PubMed ID: 22190398 [TBL] [Abstract][Full Text] [Related]
17. A comparison of non-toxin vaccine adjuvants for their ability to enhance the immunogenicity of nasally-administered anthrax recombinant protective antigen. Gwinn WM; Johnson BT; Kirwan SM; Sobel AE; Abraham SN; Gunn MD; Staats HF Vaccine; 2013 Mar; 31(11):1480-9. PubMed ID: 23352329 [TBL] [Abstract][Full Text] [Related]